Apnea, hypoventilation and pulmonary hypertension: Pathology review

3,366views

Apnea, hypoventilation and pulmonary hypertension: Pathology review

Watch later

Watch later

Sepsis
Infective endocarditis: Clinical
Endocarditis: Pathology review
Endocarditis
Fever of unknown origin: Clinical
Salmonella typhi (typhoid fever)
Plasmodium species (Malaria)
Schistosomes
Zinc deficiency and protein-energy malnutrition: Pathology review
Hypophosphatemia
Hyponatremia
Hyponatremia: Clinical
Hypertriglyceridemia
Hypertensive disorders of pregnancy: Clinical
Preeclampsia & eclampsia
Gestational hypertension
Gestational diabetes
Contraception: Clinical
Preterm labor
Erectile dysfunction
PDE5 inhibitors
Fallopian tube and uterus histology
Endometriosis
Chlamydia trachomatis
Neisseria gonorrhoeae
Treponema pallidum (Syphilis)
Congenital syphilis
Sexually transmitted infections: Clinical
HIV (AIDS)
Herpes simplex virus
Human papillomavirus
Endometrial hyperplasia
Endometrial cancer
Endometrial hyperplasia and cancer: Clinical
Ovarian cysts and tumors: Pathology review
Cervical cancer
Cervical cancer: Clinical
Cervical cancer: Pathology review
Ectopic pregnancy
Endometritis
Pelvic inflammatory disease
Ovarian germ cell tumors
Ovarian cysts, cancer, and other adnexal masses: Clinical
Sexual dysfunctions: Clinical
Anatomy clinical correlates: Wrist and hand
Placenta previa
Placental abruption
Vaginal versus cesarean delivery: Clinical
Antepartum hemorrhage: Clinical
Postpartum hemorrhage
Postpartum hemorrhage: Clinical
Urinary incontinence
Stages of labor
Shock
Shock: Clinical
Shock: Pathology review
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Opioid antagonists
Syncope: Clinical
Hypertension: Clinical
Hypertension
Hypertension: Pathology review
Local anesthetics
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Ventricular fibrillation
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Atrial fibrillation
Atrial flutter
Ventricular tachycardia
Premature ventricular contraction
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Nephrotic syndromes: Pathology review
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Frank-Starling relationship
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Pericarditis and pericardial effusion
Atherosclerosis and arteriosclerosis: Pathology review
Angina pectoris
Leg ulcers: Clinical
Chronic venous insufficiency
Ischemic stroke
Stroke: Clinical
ECG cardiac hypertrophy and enlargement
Hypertrophic cardiomyopathy
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Long QT syndrome and Torsade de pointes
Brugada syndrome
Action potentials in pacemaker cells
Asthma
Asthma: Clinical
Pneumonia
Pneumonia: Clinical
Pneumonia: Pathology review
Streptococcus pneumoniae
Pneumocystis jirovecii (Pneumocystis pneumonia)
Reading a chest X-ray
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Upper respiratory tract infection
General anesthetics
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Sleep apnea
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Sleep disorders: Clinical
Sleep
Narcolepsy (NORD)
Clinical Skills: BiPAP and CPAP
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Diffuse parenchymal lung disease: Clinical
Idiopathic pulmonary fibrosis
Hypersensitivity pneumonitis
Sarcoidosis
Acetaminophen (Paracetamol)
Paracetamol toxicity
Non-steroidal anti-inflammatory drugs
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Advanced cardiac life support (ACLS): Clinical
Respiratory acidosis
Pancoast tumor
Congenital cytomegalovirus (NORD)
Congenital TORCH infections: Pathology review
Alport syndrome
Pediatric ear, nose, and throat conditions: Clinical
Turner syndrome
Down syndrome (Trisomy 21)
Developmental milestones: Clinical
Neonatal sepsis
Auditory transduction and pathways
Muscular dystrophy
Cerebral palsy
Respiratory syncytial virus
Respiratory distress syndrome: Pathology review
Newborn management: Clinical
Neonatal respiratory distress syndrome
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Meckel diverticulum
Neonatal jaundice: Clinical
Hirschsprung disease
Congenital gastrointestinal disorders: Pathology review
Pediatric allergies: Clinical
Pediatric constipation: Clinical
Pediatric vomiting: Clinical
Febrile seizure
Rotator cuff tear
Carpal tunnel syndrome
Achilles tendon rupture
Patellar tendon rupture
Anterior cruciate ligament injury
Spinal disc herniation
Sciatica
Degenerative disc disease
Compartment syndrome
Osteomyelitis
Bone tumors
Osteoporosis
Osteomalacia and rickets
Osteoarthritis
Rheumatoid arthritis
Gout
Psoriatic arthritis
Ankylosing spondylitis
Septic arthritis
Bursitis
Polymyositis
Dermatomyositis
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Sjogren syndrome
Systemic lupus erythematosus
Raynaud phenomenon
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Sensitivity and specificity
Positive and negative predictive value
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Cystic fibrosis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Phenylketonuria (NORD)
Non-corticosteroid immunosuppressants and immunotherapies
Glucocorticoids
Child abuse: Clinical
Abdominal hernias
Hernias: Clinical
Inguinal hernia
Femoral hernia
Volvulus
Varicocele
Nutcracker syndrome
Testicular tumors: Pathology review
Testicular torsion
Intestinal atresia
Tracheoesophageal fistula
Necrotizing enterocolitis
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Gestational diabetes
Hypoglycemics: Insulin secretagogues
Insulins
Diabetic nephropathy
Diabetic retinopathy
Diabetes insipidus
Insulin
Diabetes insipidus and SIADH: Pathology review
Pituitary gland histology
Anatomy of the thyroid and parathyroid glands
Thyroid and parathyroid gland histology
Pituitary tumors: Pathology review
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Acromegaly
Gigantism
Hypopituitarism
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Hyperpituitarism
Pituitary apoplexy
Adrenal gland histology
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Adrenal insufficiency: Pathology review
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Hashimoto thyroiditis
Thyroid storm
Thyroid hormones
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hyperthyroidism medications
Hypothyroidism
Hypothyroidism medications
Hypothyroidism: Pathology review
Toxic multinodular goiter
Graves disease
Cortisol
Renin-angiotensin-aldosterone system
Conn syndrome
Waterhouse-Friderichsen syndrome
Adrenal masses and tumors: Clinical
Adrenal masses: Pathology review
Skin cancer
Skin cancer: Pathology review
Skin cancer: Clinical
Sarcoptes scabiei (Scabies)
Anti-mite and louse medications
Psoriasis
Psoriatic arthritis
Eczematous rashes: Clinical
Atopic dermatitis
Contact dermatitis
Seborrhoeic dermatitis
Keratitis
Miscellaneous antifungal medications
Azoles

Transcript

Watch video only

Joseph, a 42 year old man comes to the clinic because he’s been waking up many times at night, which makes him very sleepy during the day.

His partner also complains that Joseph has always snored but recently it’s louder than ever.

On physical examination he has a BMI of 35 kilograms per square meter, and has a blood pressure of 140 over 90 millimeters of mercury.

You decide to conduct a sleep study, which reveals a very low partial pressure of oxygen.

Later, a 35 year old woman called Robin also comes to the clinic.

She tells you that, lately, she’s been experiencing shortness of breath and fatigue.

Robin is quite worried, and mentions that she has a congenital heart defect.

On physical examination, she has a mean pulmonary arterial pressure of 28 millimeters of mercury.

You decide to perform an electrocardiogram or ECG test, and a chest X-ray, which show that Robin has right ventricular hypertrophy.

Based on the presentation, both cases seem to have some respiratory disease, associated with some cardiovascular issues.

Now, for your exams, some important conditions include sleep apnea, obesity hypoventilation syndrome, and pulmonary hypertension.

So, let’s begin with sleep apnea!

This is when a person, during their sleep, experiences recurrent and intermittent episodes in which they stop breathing for more than 10 seconds.

In addition, since fresh air is not getting into the lungs, individuals with sleep apnea will have nocturnal hypoxia.

This puts the body under stress, which in turn responds by releasing epinephrine.

Now, the recurrent epinephrine surges have several effects.

Firstly, this wakes up the person so that they can breathe again.

This causes disrupted sleep, which in turn leads to somnolence or sleepiness during the day or while awake.

Secondly, the body tries to compensate for the hypoxia by increasing the amount of red blood cells, or erythrocytes, available to carry the oxygen in blood to our tissues.

To do so, our kidneys produce a hormone called erythropoietin, or EPO, which stimulates the bone marrow to produce more red blood cells, and this process is known as erythropoiesis.

The problem with sleep apnea though is that, even if we increase the number of red blood cells, the amount of oxygen that’s entering the body is not enough, so there’s still hypoxia.

Third, having high epinephrine levels can cause vasoconstriction, increasing the vascular resistance.

Over time, this can result in vascular remodeling, which can lead to the development of both pulmonary and systemic hypertension.

Pulmonary hypertension is when the blood pressure in the lung arteries is increased, while systemic hypertension involves the arteries of the rest of the body.

Over time, this can put too much strain on the heart, and ultimately cause abnormal heart rhythms, like atrial fibrillation or atrial flutter, heart failure, and even sudden death.

Diagnosis of sleep apnea involves a sleep study, also known as polysomnography, which counts the number of apnea episodes, and monitors several parameters like heart rhythm and oxygen saturation.

Another important diagnostic value is partial pressure of oxygen in the arteries, since it helps us understand if the tissues are receiving adequate oxygen supply.

This value can be easily and indirectly obtained with a pulse oximeter, or directly obtained via blood gas sampling.

For your exams, remember that people with sleep apnea have low oxygen saturation levels, and thus low partial arterial pressure of oxygen during sleep, but bear in mind that this partial pressure is typically normal when they’re awake.

Now, when the cause of sleep apnea originates in the central nervous system, it’s called central sleep apnea.

Most often though, sleep apnea is caused by an obstruction of airflow in the airways, which is known as obstructive sleep apnea.

And when a person experiences both obstructive and central sleep apnea, it’s called complex or mixed sleep apnea.

Okay, let’s start with central sleep apnea or CSA for short.

Central sleep apnea is caused by an imbalance in the respiratory center of the brain, so during sleep it fails to activate the muscles that control breathing.

The main causes of central sleep apnea include central nervous system injury involving the respiratory center, as well as central nervous system toxicity, often due to use of opioid medications.

Another major risk factor for central sleep apnea is congestive heart failure.

What’s important for your exams is that congestive heart failure leads to increased chemosensitivity, which is how the body senses and responds to changes in the partial pressures of oxygen and carbon dioxide.

So when there’s an apnea episode, oxygen levels decrease while carbon dioxide levels rise.

Now, keep in mind that carbon dioxide is the main stimulus for the respiratory center, so when there are high levels of carbon dioxide, the respiratory center responds by increasing our respiratory rate.

Now, when there’s increased chemosensitivity, the increased CO2 triggers an exaggerated response in the form of hyperventilation, and ends up decreasing the carbon dioxide too much.

So now the CO2 level is too low, and this ultimately causes depression of the respiratory center and thus another apnea episode.

As a result, there’s a vicious cycle that leads to central sleep apnea.

Now, when central sleep apnea is associated with congestive heart failure, it often manifests as an abnormal breathing pattern called Cheyne-Stokes respiration, also known as cyclic respiration.

This is a periodic breathing characterized by oscillation between periods of apnea alternated with deep breaths or hyperpnea.

So, for your exams, remember that the three main things you need to know all start with a ‘C’ for central sleep apnea!

The first is central nervous system injury or toxicity, the second ‘c’ is congestive heart failure, and the third ‘c’ is for- Cheyne-Stokes respiration.

Treatment of central sleep apnea mainly involves positive airway pressure therapy, as well as taking care of the underlying cause.

And then we have obstructive sleep apnea, or OSA for short.

As the name suggests, it is caused by a narrowing or obstruction of the airways.

Now, normally, the airway muscles relax while sleeping

In healthy people though, the airway muscle tone is strong enough to counteract factors that would cause the airway to collapse, such as gravity while lying down, and the negative pressure in the airway during inspiration.

In obstructive sleep apnea, the airway muscle tone is not strong enough to counteract these factors, and so the airway collapses.

In adults, the most common cause is an excess of parapharyngeal tissue, which basically means that there’s excess fat in the neck region.

That’s why obstructive sleep apnea is most common in obese individuals, so those with a BMI over 30 kilograms per square meter.

On a test question, the most important clue suggesting obstructive sleep apnea is loud snoring in an obese individual, like they’re trying to gasp for air until they wake up.

This leads to disrupted sleep, which in turn causes excessive sleepiness during the day or while awake.

Sometimes though, obstructive sleep apnea may affect children; in this case, the most common cause is adenotonsillar hypertrophy, meaning an enlargement of the pharyngeal and palatine tonsils.

Treatment of obstructive sleep apnea involves continuous positive airway pressure, or CPAP therapy, which delivers a steady stream of pressure, in order to keep the airway open.

In addition, weight loss is highly recommended for overweight people.

Finally, one last option is surgery to remove the excess parapharyngeal tissue.

Now, another important respiratory disease that’s very often related to obstructive sleep apnea is obesity hypoventilation syndrome, or OHS for short.

Obesity hypoventilation syndrome is also named Pickwickian syndrome after Charles Dickens’ novel “The Pickwick Papers”, in which there is an overweight character who’s constantly falling asleep at any time of the day.

As the name suggests, obesity hypoventilation syndrome only affects obese individuals.

That’s because the excess weight can restrict the movement of the diaphragm and chest wall, which impairs lung expansion.

As a result, affected individuals develop hypoventilation, meaning slow or shallow breathing.

In most cases, obesity hypoventilation syndrome also causes obstructive sleep apnea and hypoventilation during sleep, but bear in mind that these individuals also experience hypoventilation while awake.

And that’s a high yield fact!

Because of that, diagnosis of obesity hypoventilation syndrome includes an increased partial pressure of carbon dioxide while awake, and while sleeping, they’ll also have a decreased partial pressure of oxygen.

Treatment is mainly focused on weight loss, and some cases can also get positive airway pressure during sleep.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Diagnostic and Statistical Manual of Mental Disorders" A.P. Association and A.P.A.T.F.O.N.A. Statistics (1980)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Sleep Apnoea In The Older Adult" Drugs & Aging (2003)
  7. "Obesity hypoventilation syndrome" European Respiratory Review (2019)
  8. "Pathology of Pulmonary Hypertension" Clinics in Chest Medicine (2007)
  9. "Plexiform Lesions in Pulmonary Arterial Hypertension" The American Journal of Pathology (2011)
  10. "Heart rate and blood pressure responses during hypoxic cycles of a 3-week intermittent hypoxia breathing program in patients at risk for or with mild COPD" International Journal of Chronic Obstructive Pulmonary Disease (2015)
  11. "Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences" Clinics (2005)
  12. "Congestive Heart Failure and Central Sleep Apnea" Critical Care Clinics (2015)
  13. "Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018" International Journal of Cardiology (2018)
  14. "Update on Chronic Thromboembolic Pulmonary Hypertension" Circulation (2014)